Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

197 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism.
Bouloux P, Warne DW, Loumaye E; FSH Study Group in Men's Infertility. Bouloux P, et al. Fertil Steril. 2002 Feb;77(2):270-3. doi: 10.1016/s0015-0282(01)02973-9. Fertil Steril. 2002. PMID: 11821082 Clinical Trial.
Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism.
Kirk JM, Savage MO, Grant DB, Bouloux PM, Besser GM. Kirk JM, et al. Among authors: bouloux pm. Clin Endocrinol (Oxf). 1994 Jul;41(1):57-63. doi: 10.1111/j.1365-2265.1994.tb03785.x. Clin Endocrinol (Oxf). 1994. PMID: 7914153

The non-cryptorchid group achieved a higher mean testicular volume on hCG therapy than the cryptorchid group (mean (SD); 4.7 (1.8) ml vs 3.0 (1.6) ml (P < 0.02)), and for all patients there was a correlation between initial and maximal testicular volume (R = 0.69, P

The non-cryptorchid group achieved a higher mean testicular volume on hCG therapy than the cryptorchid group (mean (SD); 4.7 (1.8) ml vs 3.0 …
X-linked ichthyosis with hypogonadism: not always Kallmann's syndrome.
Quinton R, Schofield JK, Duke VM, Bouloux PM, Buchanan CR, Leigh IM, Wood DF. Quinton R, et al. Among authors: bouloux pm. Clin Exp Dermatol. 1997 Jul;22(4):201-4. Clin Exp Dermatol. 1997. PMID: 9499614
Growth hormone deficiency and atherosclerosis--is there a link?
McGrath S, Morris M, Bouloux PM. McGrath S, et al. Among authors: bouloux pm. Growth Horm IGF Res. 1999 Apr;9 Suppl A:9-13. doi: 10.1016/s1096-6374(99)80003-3. Growth Horm IGF Res. 1999. PMID: 10429874 Review. No abstract available.
Gordon Holmes spinocerebellar ataxia: a gonadotrophin deficiency syndrome resistant to treatment with pulsatile gonadotrophin-releasing hormone.
Quinton R, Barnett P, Coskeran P, Bouloux PM. Quinton R, et al. Among authors: bouloux pm. Clin Endocrinol (Oxf). 1999 Oct;51(4):525-9. doi: 10.1046/j.1365-2265.1999.00859.x. Clin Endocrinol (Oxf). 1999. PMID: 10583322
First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.
Bouloux PM, Handelsman DJ, Jockenhövel F, Nieschlag E, Rabinovici J, Frasa WL, de Bie JJ, Voortman G, Itskovitz-Eldor J; FSH-CTP study group. Bouloux PM, et al. Hum Reprod. 2001 Aug;16(8):1592-7. doi: 10.1093/humrep/16.8.1592. Hum Reprod. 2001. PMID: 11473948 Clinical Trial.
The sweating apparatus in growth hormone deficiency, following treatment with r-hGH and in acromegaly.
Hasan W, Cowen T, Barnett PS, Elliot E, Coskeran P, Bouloux PM. Hasan W, et al. Among authors: bouloux pm. Auton Neurosci. 2001 Jun 20;89(1-2):100-9. doi: 10.1016/S1566-0702(01)00257-0. Auton Neurosci. 2001. PMID: 11474638 Clinical Trial.
Delivery of testosterone replacement therapy.
Hameed A, Brothwood T, Bouloux P. Hameed A, et al. Among authors: bouloux p. Curr Opin Investig Drugs. 2003 Oct;4(10):1213-9. Curr Opin Investig Drugs. 2003. PMID: 14649214 Review.
Ontogeny of GnRH and olfactory neuronal systems in man: novel insights from the investigation of inherited forms of Kallmann's syndrome.
González-Martínez D, Hu Y, Bouloux PM. González-Martínez D, et al. Among authors: bouloux pm. Front Neuroendocrinol. 2004 Jul;25(2):108-30. doi: 10.1016/j.yfrne.2004.06.001. Front Neuroendocrinol. 2004. PMID: 15571757
Testim 1% testosterone gel for the treatment of male hypogonadism.
Bouloux P. Bouloux P. Clin Ther. 2005 Mar;27(3):286-98. doi: 10.1016/j.dinthera.2005.02.015. Clin Ther. 2005. PMID: 15878382 Review.

In a 30-day study of 638 men with hypogonadism, sexual desire scores and sexual motivation scores increased after Testim treatment at weeks 1, 2, 3, and 4 (each, P < 0.001). During 12 months of treatment with Testim 50 or 100 mg in 371 men with hypogonadism, total serum

In a 30-day study of 638 men with hypogonadism, sexual desire scores and sexual motivation scores increased after Testim treatment at weeks …
197 results
Jump to page
Feedback